Home Blog


16 October 2017
We look at why data protection is changing, what the new rules look like and how you can be best prepared for GDPR. This follows hot on the heels from a recent article suggesting that a fifth of charities that took part in a recent GDPR survey had not yet taken any steps to prepare for the new regulation.
12 October 2017
AMRC member Autistica launches Discover, the first national network for autism research. Jon Adams, autistic artist, encourages autistic people to ensure their voice is heard.
9 October 2017
AMRC’s party conference season activity came to an end last week with two successful roundtable meetings under our belts. We co-hosted roundtables at both the Labour and Conservative party conferences alongside our industry partners the BIA, ABPI and BIVDA.
14 September 2017
Jane Spillman, Executive Search Consultant at Horton International discusses what makes a successful charity employee and explores factors for consideration when moving into the charity sector.
7 September 2017
Nicole Harmon, Chief of Staff at CDISC, a global, non-profit charitable organisation, tells us about their Therapeutic Area User Guides and how they can help your studies 'speak the same language'.
29 August 2017
On Wednesday 30 August the Life Sciences Industrial Strategy was published. AMRC's Aisling Burnand explores what the Strategy means for medical research charities and the next step, the 'sector deal'.
23 August 2017
A guest blog from our newest supporter Covance, the drug development division of LabCorp recently released on www.Covance.com from Jonathan Zhung, Group President of Clinical Development Commercialization Services discussing the importance of patient centricity within a CRO.
18 August 2017
Rebecca Torr, Senior Copy Editor at Research Media, the creative agency that helped develop AMRC's 'Making a difference' digital report, explains the importance of communicating the impact of your research and what innovative methods you can use to do this.
11 August 2017
Along with Public Health England and Alzheimer’s Society, Alzheimer’s Research UK ran an innovative pilot project which saw, for the first time, dementia risk reduction messages delivered to 40-64-year-olds during their NHS Health Check.
4 August 2017
Earlier this year, 8 March 2017, Parkinson’s UK and the University of Sheffield launched a new £1 million virtual biotech company, Keapstone Therapeutics, as part of a research programme to create novel medicines for Parkinson’s disease. Arthur Roach, Director of Research and Development at Parkinson’s UK spoke to AMRC about the partnership and the resulting spin-out company.